ARSEUS Stock Euronext Amsterdam
Stocks
BE0003874915
Pharmaceuticals
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
||
| 22.38 EUR | 0.00% |
|
| 08-01 | Fagron NV, H1 2026 Earnings Call, Jul 30, 2026 | |
| 07-30 | Fagron NV Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 1.65B 1.91B 1.54B 1.42B 2.67B 182B 2.71B 18.12B 7.11B 91.21B 7.18B 7.02B 302B | P/E 2026 * |
15.5x | P/E 2027 * | 13.9x |
|---|---|---|---|---|---|
| Enterprise Value | 2.16B 2.5B 2.02B 1.85B 3.49B 238B 3.54B 23.71B 9.31B 119B 9.39B 9.19B 395B | EV / Sales 2026 * |
1.9x | EV / Sales 2027 * | 1.7x |
| Free-Float |
71.36% | Yield 2026 * |
1.89% | Yield 2027 * | 2.02% |
Last Transcript: ARSEUS
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 48 | 27/11/2017 | |
Karin de Jong
DFI | Director of Finance/CFO | 47 | 01/05/2016 |
Vera Bakker
COO | Chief Operating Officer | 54 | 09/05/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Karin de Jong
BRD | Director/Board Member | 47 | 01/05/2016 |
Koen Hoffman
CHM | Chairman | 58 | 09/05/2017 |
| Director/Board Member | 48 | 07/02/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.52% | +3.21% | +89.52% | +125.32% | 1,057B | |
| +0.88% | +1.13% | +49.56% | +49.79% | 625B | |
| +0.89% | -1.95% | +24.23% | +63.19% | 435B | |
| +0.79% | +4.02% | +50.35% | +38.74% | 363B | |
| +0.08% | +1.27% | +31.31% | +39.19% | 296B | |
| +0.11% | +3.44% | +7.79% | +6.58% | 249B | |
| +1.51% | +6.69% | +42.58% | +58.47% | 222B | |
| -0.87% | +0.02% | -6.28% | -51.55% | 209B | |
| +1.80% | +2.30% | +11.56% | +66.16% | 165B | |
| Average | +0.29% | +0.94% | +33.40% | +43.99% | 402.31B | |
| Weighted average by Cap. | +0.14% | +1.33% | +48.52% | +63.94% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.14B 1.32B 1.06B 977M 1.84B 125B 1.87B 12.49B 4.9B 62.89B 4.95B 4.84B 208B | 1.24B 1.43B 1.16B 1.06B 2B 136B 2.03B 13.58B 5.33B 68.35B 5.38B 5.26B 226B |
| Net income | 107M 124M 99.77M 91.52M 172M 11.75B 175M 1.17B 459M 5.89B 464M 454M 19.48B | 119M 138M 112M 102M 193M 13.14B 196M 1.31B 514M 6.59B 519M 507M 21.78B |
| Net Debt | 510M 590M 476M 437M 822M 56.12B 835M 5.59B 2.19B 28.13B 2.21B 2.17B 93B | 450M 520M 420M 385M 725M 49.5B 736M 4.93B 1.93B 24.81B 1.95B 1.91B 82.02B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
